CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 22, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a global strategic...
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers )
Also on site :
- A Local Mystic's Favorite Spots in "Witch City" Salem, MA
- ‘Contaminated’ snack sold at Trader Joe’s recalled after ‘life-threatening’ bacteria found – 4 groups at higher risk
- Bianca Censori Wears Edible Lingerie in Public With Kanye West